Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Franco-Nevada
FNV
$45.2B
| $34.6M | 0.05% |
528,600
-309,500
| -37% | -$19.9M |
|
502
Church & Dwight Co
CHD
$24.2B
| $34.5M | 0.05% |
692,230
+627,830
| +975% | +$30M |
|
|
NFBK
503
DELISTED
Northfield Bancorp
NFBK
| $34.3M | 0.05% |
1,903,268
+76,200
| +4% | +$1.4M |
|
504
Prologis
PLD
$133B
| $34.2M | 0.05% |
659,671
-433,300
| -40% | -$22M |
|
|
SODA
505
DELISTED
SodaStream International Ltd
SODA
| $34.1M | 0.05% |
705,000
+61,800
| +10% | +$2.81M |
|
506
Haverty Furniture Companies
HVT
$438M
| $34.1M | 0.05% |
1,401,100
+35,600
| +3% | +$816K |
|
507
Check Point Software Technologies
CHKP
$13.1B
| $34.1M | 0.05% |
+332,208
| New | +$32.6M |
|
508
CDW
CDW
$17.1B
| $34M | 0.05% |
+588,598
| New | +$33.1M |
|
|
WBK
509
DELISTED
Westpac Banking Corporation
WBK
| $33.9M | 0.05% |
1,269,300
-148,266
| -10% | -$3.77M |
|
510
OceanFirst Financial
OCFC
$1.85B
| $33.9M | 0.05% |
1,201,691
+267,900
| +29% | +$7.79M |
|
511
Capital One
COF
$135B
| $33.8M | 0.05% |
+390,499
| New | +$34.8M |
|
|
DF
512
DELISTED
Dean Foods Company
DF
| $33.8M | 0.05% |
1,719,950
+537,900
| +46% | +$10.5M |
|
513
Exelixis
EXEL
$12.6B
| $33.8M | 0.05% |
1,558,060
+247,550
| +19% | +$5.03M |
|
514
Valley National Bancorp
VLY
$8.21B
| $33.7M | 0.05% |
2,855,688
-338,412
| -11% | -$4.06M |
|
515
Textron
TXT
$15.2B
| $33.7M | 0.05% |
707,200
+428,200
| +153% | +$20.7M |
|
516
MarketAxess Holdings
MKTX
$5.72B
| $33.6M | 0.05% |
179,110
-4,400
| -2% | -$798K |
|
|
DDC
517
DELISTED
Dominion Diamond Corporation
DDC
| $33.5M | 0.05% |
2,651,398
-197,500
| -7% | -$1.99M |
|
518
Valmont Industries
VMI
$9.55B
| $33.4M | 0.05% |
214,800
-16,653
| -7% | -$2.46M |
|
519
Synopsys
SNPS
$79.2B
| $33.4M | 0.05% |
462,734
+199,500
| +76% | +$13.4M |
|
|
RPXC
520
DELISTED
RPX Corporation
RPXC
| $33.3M | 0.05% |
2,774,900
+197,800
| +8% | +$2.24M |
|
|
SBNY
521
DELISTED
Signature Bank
SBNY
| $33.3M | 0.05% |
224,174
+64,200
| +40% | +$9.94M |
|
522
Haemonetics
HAE
$4.06B
| $33.2M | 0.05% |
818,600
-76,600
| -9% | -$2.99M |
|
523
Sprouts Farmers Market
SFM
$7.85B
| $33.2M | 0.05% |
1,436,400
+1,117,000
| +350% | +$21.9M |
|
|
RGC
524
DELISTED
Regal Entertainment Group
RGC
| $33.2M | 0.05% |
1,468,800
+650,800
| +80% | +$14.4M |
|
|
ELME
525
Elme Communities
ELME
$145M
| $33.1M | 0.05% |
1,058,300
+178,300
| +20% | +$5.69M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.